Thorlacius-Ussing O - Search Results

1

Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma.

Zimmermann-Nielsen E, Baatrup G, Thorlacius-Ussing O, Agnholt J, Svehag SE. Zimmermann-Nielsen E, et al. Scand J Immunol. 2002 Jan;55(1):105-10. doi: 10.1046/j.1365-3083.2002.01035.x. Scand J Immunol. 2002. PMID: 11841698 Free article.

2

ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes.

Zimmermann-Nielsen E, Svehag SE, Thorlacius-Ussing O, Baatrup G. Zimmermann-Nielsen E, et al. J Immunol Methods. 2001 Mar 1;249(1-2):43-51. doi: 10.1016/s0022-1759(00)00281-7. J Immunol Methods. 2001. PMID: 11226462

3

Activation capacity of the alternative and classic complement pathways in patients operated on for colorectal cancer.

Zimmermann-Nielsen E, Iversen LH, Svehag SE, Thorlacius-Ussing O, Baatrup G. Zimmermann-Nielsen E, et al. Dis Colon Rectum. 2002 Apr;45(4):544-53. doi: 10.1007/s10350-004-6237-6. Dis Colon Rectum. 2002. PMID: 12006940

4

Inverted Meckel's diverticulum masquerading Crohn disease in the small intestine.

Henneberg Holmboe C, Thorlacius-Ussing O, Teglbjaerg PS, Vinter-Jensen L. Henneberg Holmboe C, et al. Scand J Gastroenterol. 2003 Feb;38(2):225-7. Scand J Gastroenterol. 2003. PMID: 12678342

5

Complement activation in plasma before and after infliximab treatment in Crohn disease.

Zimmermann-Nielsen E, Agnholt J, Thorlacius-Ussing O, Dahlerup JF, Baatrup G. Zimmermann-Nielsen E, et al. Scand J Gastroenterol. 2003 Oct;38(10):1050-4. doi: 10.1080/00365520310005767. Scand J Gastroenterol. 2003. PMID: 14621279

6

Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.

Zimmermann-Nielsen E, Grønbaek H, Dahlerup JF, Baatrup G, Thorlacius-Ussing O. Zimmermann-Nielsen E, et al. BMC Gastroenterol. 2005 Sep 22;5:31. doi: 10.1186/1471-230X-5-31. BMC Gastroenterol. 2005. PMID: 16179087 Free PMC article.

7

Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease.

Iversen LH, Thorlacius-Ussing O, Okholm M. Iversen LH, et al. Thromb Res. 1995 Sep 15;79(5-6):471-81. doi: 10.1016/0049-3848(95)00137-g. Thromb Res. 1995. PMID: 7502273

8

Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma.

Okholm M, Iversen LH, Thorlacius-Ussing O, Ejlersen E, Boesby S. Okholm M, et al. Dis Colon Rectum. 1996 Oct;39(10):1102-6. doi: 10.1007/BF02081408. Dis Colon Rectum. 1996. PMID: 8831523

9

Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.

Iversen LH, Okholm M, Thorlacius-Ussing O. Iversen LH, et al. Thromb Haemost. 1996 Oct;76(4):523-8. Thromb Haemost. 1996. PMID: 8902990 Clinical Trial.

10

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.

Nielsen HJ, Pappot H, Christensen IJ, Brünner N, Thorlacius-Ussing O, Moesgaard F, Danø K, Grøndahl-Hansen J. Nielsen HJ, et al. BMJ. 1998 Mar 14;316(7134):829-30. doi: 10.1136/bmj.316.7134.829. BMJ. 1998. PMID: 9549453 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters